Agentic AI in Pharma Supply Chains: From Insights to Autonomous Decisions

Artificial Intelligence is entering a new phase in pharmaceutical supply chains. Beyond forecasting and analytics, Agentic AI promises to transform how companies anticipate disruptions, coordinate operations and make decisions across increasingly complex global networks. While traditional AI primarily supports analysis and predictions, Agentic AI introduces intelligent agents capable of interpreting situations, coordinating workflows and initiating…

EU Biotech Act: A New Opportunity to Strengthen European Life Sciences Supply Chains?

Europe is entering a new phase in its biotechnology strategy. The proposed EU Biotech Act could become an important catalyst for strengthening European competitiveness, accelerating innovation and developing more resilient life sciences supply chains. But what does this mean in practice for the industry? The European Commission’s proposal for the EU Biotech Act, presented in…